Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Academic History

Piotr Rutkowski, MD, PhD, is the Head of the Department of Soft Tissue/Bone Sarcoma and Melanoma and Pluripotency Director of the Institute for Clinical Trials at the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. Prof. Rutkowski gained his medical degree from the Medical University of Lodz, Lodz, Poland, and completed his PhD at the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology. Prof. Rutkowski is the Coordinator of the Polish Clinical GIST Registry and an active member of the EORTC Soft Tissue and Bone Sarcoma Group. He has chaired the Local Treatment Subcommittee and Membership Committee of the EORTC board and is an active member of the EORTC Melanoma Group and Global Melanoma Task Force.

Speaking on novel therapies and precision medicine in melanoma and sarcoma

Prof. Rutkowski is involved in several investigator-driven trials in melanoma and sarcoma. In melanoma, he has an interest in disease biology, and the use of immunotherapy and targeted therapies. He has carried out research to identify predictors of response and optimize treatment for patients with gastrointestinal stromal tumors (GIST). Prof. Rutkowski also has an interest in the personalization of perioperative therapy to limit the extent of surgery in melanoma and in molecular profiling of soft tissue sarcomas.

Sorry, no posts matched your criteria.